We are live on ! Find out more
PCA

Private Capital Advisors Portfolio holdings

AUM $1.15B Turnover 18.82%
1-Year Est. Return 43.46%
This Fund
S&P 500
This Quarter Est. Return
+10.64%
1 Year Est. Return
+43.46%
3 Year Est. Return
+131.91%
5 Year Est. Return
+229.29%
10 Year Est. Return
+757.55%
AUM
$269M
AUM Growth
–
Cap. Flow
+$264M
Cap. Flow %
98.02%
Top 10 Hldgs %
27.65%
Holding
112
New
112
Increased
–
Reduced
–
Closed
–
Avg Time Held
0 years
Top 10 Avg Time Held
0 years
Top 20 Avg Time Held
0 years

Top Buys

Rank Stock Value
1
CLDX icon
Celldex Therapeutics
CLDX
+$10.8M
2
RH icon
RH
RH
+$10.3M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$7.56M
4
AAPL icon
Apple
AAPL
+$6.29M
5
EPD icon
Enterprise Products Partners
EPD
+$6.18M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 22.57%
2 Energy 19.28%
3 Communication Services 12.18%
4 Industrials 9.72%
5 Technology 7.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
GILD icon
26
Gilead Sciences
GILD
$195B
$3.8M 1.41%
+74,194
New +$3.87M
2013 Q2
0 quarters
NWSA icon
27
DELISTED
NEWS CORPORATION CL-A
NWSA
$3.77M 1.4%
+115,625
New +$3.68M
2013 Q2
0 quarters
PARA icon
28
DELISTED
Paramount Global Class B
PARA
$3.69M 1.37%
+75,552
New +$3.45M
2013 Q2
0 quarters
DHR icon
29
Danaher
DHR
$163B
$3.69M 1.37%
+86,635
New +$3.59M
2013 Q2
0 quarters
UBA
30
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
$3.68M 1.37%
+182,649
New +$3.96M
2013 Q2
0 quarters
T icon
31
AT&T
T
$161B
$3.64M 1.35%
+136,058
New +$3.78M
2013 Q2
0 quarters
CNI icon
32
Canadian National Railway
CNI
$72.9B
$3.56M 1.32%
+73,240
New +$3.61M
2013 Q2
0 quarters
ESV
33
DELISTED
Ensco Rowan plc
ESV
$3.46M 1.28%
+14,881
New +$3.5M
2013 Q2
0 quarters
VOD icon
34
Vodafone
VOD
$36.7B
$3.44M 1.28%
+117,309
New +$3.5M
2013 Q2
0 quarters
LBTYK icon
35
Liberty Global Class C
LBTYK
$2.69B
$3.41M 1.27%
+124,215
New +$3.48M
2013 Q2
0 quarters
SNY icon
36
Sanofi
SNY
$96.5B
$3.35M 1.24%
+65,075
New +$3.47M
2013 Q2
0 quarters
PM icon
37
Philip Morris
PM
$312B
$3.32M 1.23%
+38,300
New +$3.56M
2013 Q2
0 quarters
MMM icon
38
3M
MMM
$85.3B
$3.27M 1.22%
+35,796
New +$3.25M
2013 Q2
0 quarters
CVX icon
39
Chevron
CVX
$430B
$3.27M 1.21%
+27,635
New +$3.34M
2013 Q2
0 quarters
KO icon
40
Coca-Cola
KO
$396B
$3.25M 1.21%
+80,956
New +$3.35M
2013 Q2
0 quarters
TYPE
41
DELISTED
Monotype Imaging Holdings Inc.
TYPE
$3.17M 1.18%
+124,915
New +$2.91M
2013 Q2
0 quarters
BAY icon
42
DELISTED
BAYER AG SPONS ADR
BAY
$2.99M 1.11%
+28,049
New +$2.99M
2013 Q2
0 quarters
GOOG icon
43
Alphabet (Google) Class C
GOOG
$4.22T
$2.97M 1.1%
+135,345
New +$2.86M
2013 Q2
0 quarters
MGA icon
44
Magna International
MGA
$17.8B
$2.7M 1%
+75,900
New +$2.41M
2013 Q2
0 quarters
EOG icon
45
EOG Resources
EOG
$80.1B
$2.58M 0.96%
+39,164
New +$2.51M
2013 Q2
0 quarters
NXST icon
46
Nexstar Media Group
NXST
$5.07B
$2.54M 0.94%
+71,650
New +$1.89M
2013 Q2
0 quarters
SBGI icon
47
Sinclair Inc
SBGI
$918M
$2.54M 0.94%
+86,500
New +$2.26M
2013 Q2
0 quarters
IRWD icon
48
Ironwood Pharmaceuticals
IRWD
$623M
$2.31M 0.86%
+277,605
New +$3.36M
2013 Q2
0 quarters
MOS icon
49
The Mosaic Company
MOS
$6.02B
$2.25M 0.84%
+41,864
New +$2.49M
2013 Q2
0 quarters
ARIA
50
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$2.23M 0.83%
+127,600
New +$2.26M
2013 Q2
0 quarters
1
2
3 4 5

Similar funds

WB
Webster Bank Waterbury, Connecticut $1.15B AUM 23.08% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
CFP
Cascade Financial Partners San Diego, California $1.15B AUM 33.6% 1-Year Est. Return
HT
Heritage Trust Oklahoma City, Oklahoma $1.15B AUM 35.37% 1-Year Est. Return
AA
Apriem Advisors Irvine, California $1.16B AUM 27.46% 1-Year Est. Return
CIG
Consolidated Investment Group Englewood, Colorado $1.15B AUM 55.26% 1-Year Est. Return
CIS
Connors Investor Services Wyomissing, Pennsylvania $1.16B AUM 27.24% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $1.15B AUM 24.81% 1-Year Est. Return

Private Capital Advisors's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Private Capital Advisors, which disclosed 112 positions worth $269M. Its ten largest holdings account for 28% of the portfolio.

Its largest position is Celldex Therapeutics: 54,837 shares worth $12.8M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, followed by Energy and Communication Services.

  • Private Capital Advisors's largest Q2 2013 buy was Celldex Therapeutics: 54,837 shares worth $12.8M.
  • Private Capital Advisors's ten largest holdings make up 28% of its $269M portfolio in Q2 2013.
  • Private Capital Advisors disclosed 112 positions in Q2 2013, its first 13F filing on record.

Based on Private Capital Advisors's 13F filing for Q2 2013, filed 24 Jul 2013.